Clinical trial
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
NCT05446168 is registered in ClinicalTrials.gov with Nicolaas Bohnen, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
- Lead sponsor
- Nicolaas Bohnen, MD, PhD
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- July 1, 2022
- Completion date
- September 26, 2023
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.